Pinki Prasad
Pediatric Hematology-Oncology · New Orleans, LANPI 1336296128
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,987 of the $20,179 with a category attached, or 84.2%. AstraZeneca accounts for 63.1% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2021 at $6,854 and has fallen 86.7% since, to $913 in 2025.
Across 120 payments — averaging $168.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$13K
- Vertex$4K
- Novo Nordisk$489
- Novartis$319
- Genetix Biotherapeutics Inc$316
- Sobi, Inc$249
- plus $2K from 26 others
What the payments were for
- Consulting fees$16,98784%
- Food & beverage$3,19316%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 14 | $12,736 |
| Vertex | 1 | $4,365 |
| Novo Nordisk | 15 | $489 |
| Novartis | 18 | $319 |
| Genetix Biotherapeutics Inc | 4 | $316 |
| Sobi, Inc | 8 | $249 |
| Servier Pharmaceuticals LLC | 12 | $211 |
| CSL Behring | 7 | $166 |
| Sanofi | 1 | $145 |
| BTG International Inc. | 3 | $144 |
| Incyte Corporation | 1 | $125 |
| Mesoblast, Inc. | 1 | $120 |
| Bioverativ Therapeutics Inc. | 1 | $110 |
| Octapharma USA, Inc. | 4 | $104 |
| Global Blood Therapeutics, Inc. | 6 | $97 |
| Jazz Pharmaceuticals Inc. | 3 | $77 |
| Pfizer | 4 | $69 |
| Seagen Inc. | 2 | $42 |
| Bayer | 2 | $41 |
| Eurofins Viracor, LLC | 1 | $36 |
| Fennec Pharmaceuticals, Inc. | 1 | $28 |
| Medunik USA Inc. | 1 | $25 |
| Epizyme, Inc. | 1 | $21 |
| Grifols USA, LLC | 1 | $20 |
| Chiesi USA, Inc. | 1 | $19 |
| RARE Disease Therapeutics, Inc. | 1 | $18 |
| Adaptive Biotechnologies Corporation | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Medexus Pharma, Inc. | 1 | $15 |
| USWM, LLC | 1 | $15 |
| Silvergate Pharmaceuticals, Inc. | 1 | $12 |
| Emmaus Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,179 in reported general payments places this provider in the 75th percentile of 26 pediatric hematology-oncology providers in Louisiana.
See all pediatric hematology-oncology providers in Louisiana →
Other pediatric hematology-oncology in New Orleans
- Tammuella Chrisentery-SingletonNew Orleans$1.4M
- Maria Velez-YanguasNew Orleans$105K
- Zachary LeblancNew Orleans$55K
- Dana LeblancNew Orleans$25K
- Renee GardnerNew Orleans$25K
- Robert VasquezNew Orleans$6K
- Lolie YuNew Orleans$3K
- Craig LottermanNew Orleans$3K
- Cori MorrisonNew Orleans$1K
- Justin FargeNew Orleans$797
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.